date,ticker,title,description,url
03/26/2021,BMY,"U.S. Food and Drug Administration Approves Bristol Myers Squibb’s and bluebird bio’s Abecma (idecabtagene vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed or Refractory Multiple Myeloma","Bristol Myers Squibb (NYSE: BMY) and bluebird bio, Inc. (Nasdaq: BLUE) today announced that the U.S. Food and Drug Administration (FDA) has approved Abecma (idecabtagene vicleucel; ide-cel) as the fir...",http://www.businesswire.com/news/home/20210326005507/en/U.S.-Food-and-Drug-Administration-Approves-Bristol-Myers-Squibb%E2%80%99s-and-bluebird-bio%E2%80%99s-Abecma-idecabtagene-vicleucel-the-First-Anti-BCMA-CAR-T-Cell-Therapy-for-Relapsed-or-Refractory-Multiple-Myeloma
03/26/2021,AVEO,AVEO Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares,"AVEO Oncology (Nasdaq: AVEO) today announced the closing of its previously announced underwritten public offering of 6,900,000 shares of its common stock, which includes the full exercise by the under...",http://www.businesswire.com/news/home/20210326005033/en/AVEO-Announces-Closing-of-Public-Offering-of-Common-Stock-and-Full-Exercise-of-Option-to-Purchase-Additional-Shares
03/26/2021,SPPI,Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update,"Spectrum Pharmaceuticals (NasdaqGS: SPPI) a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the fourth quarter and...",http://www.businesswire.com/news/home/20210326005352/en/Spectrum-Pharmaceuticals-to-Report-Fourth-Quarter-and-Full-Year-2020-Financial-Results-and-Provide-Corporate-Update
03/26/2021,KRBP,"Kiromic BioPharma, Inc. Interview to Air on Bloomberg Television U.S. on the RedChip Money Report","Kiromic BioPharma, Inc. (Nasdaq: KRBP) is an immuno-oncology target discovery and gene-editing company with a proprietary artificial intelligence neural network platform (Diamond AI) to develop novel...",http://www.businesswire.com/news/home/20210326005290/en/Kiromic-BioPharma-Inc.-Interview-to-Air-on-Bloomberg-Television-U.S.-on-the-RedChip-Money-Report
